Mothers and children, husbands and wives, doctors, truck drivers and religious leaders are all grappling with the fallout from the sudden U.S. cuts in aid.
Potential cuts to HIV work at the Atlanta-based Centers for Disease Control and Prevention have local and national experts worried that recent progress in cutting HIV rates will come to a halt.
The President's Emergency Plan for AIDS Relief has been the subject of a series of presidential orders and memos that have left uncertainty about how it operates.
A rule enacted by the Biden administration that took effect for many Affordable Care Act plans on Jan. 1 should make it easier for people like Wilkins to get long-acting PrEP injectable drugs — a new Trump administration adds an X factor to this and other federal health programs.
At a health expo in Clarkston, workers offering services expressed pride in their efforts to contribute to metro Atlanta’s well-being. But many worried whether moves by newly elected President Donald Trump could hamper their mission.
A series of orders from the Trump administration have the potential to disrupt the delivery of life-saving medications to HIV positive people. Here's what a disruption of this drug regimen would mean.
On Friday, a memorandum signed by Marco Rubio called for a 90-day cessation of foreign aid. That would likely put on hold the work of PEPFAR, the President's Emergency Plan for AIDS Relief.
HIV is a sexually transmitted infection (STI) that can lead to AIDS. Almost half of new HIV infections in the United States are reported in the South, and Atlanta ranks in the top five cities nationally for people living with HIV.
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that prevents infection by the HIV virus.
Almost half of new HIV infections in the United States are reported in the South, and more than 66,000 Georgians are living with the virus that causes AIDS, many of whom do not have access to health care.
This year's Lasker Prize for public service goes to South African researchers Salim and Quarraisha Abdool-Karim. The married couple made a startling discovery about HIV — and did something about it.
In newly released data, lenacapavir, given via a twice-yearly injection, has shown remarkable effectiveness at eliminating HIV transmission during sexual contact. But its cost could be an issue.
The "Dusseldorf patient" spoke at last week's AIDS 2024 conference in Munich. Here's what doctors did — and what they say about their ability to replicate the procedure.
